CN105194068A - Raynaud's disease and therapeutic drug thereof - Google Patents
Raynaud's disease and therapeutic drug thereof Download PDFInfo
- Publication number
- CN105194068A CN105194068A CN201510644592.5A CN201510644592A CN105194068A CN 105194068 A CN105194068 A CN 105194068A CN 201510644592 A CN201510644592 A CN 201510644592A CN 105194068 A CN105194068 A CN 105194068A
- Authority
- CN
- China
- Prior art keywords
- parts
- disease
- raynaud
- radix
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000012322 Raynaud phenomenon Diseases 0.000 title claims abstract description 31
- 208000003782 Raynaud disease Diseases 0.000 title claims abstract description 28
- 229940126585 therapeutic drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 33
- 241000628997 Flos Species 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 5
- 241000195474 Sargassum Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 235000016811 Biondella Nutrition 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 206010003549 asthenia Diseases 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010011703 Cyanosis Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010003175 Arterial spasm Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010047115 Vasculitis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 208000022901 Reynold syndrome Diseases 0.000 description 1
- 208000016717 Reynolds syndrome Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Raynaud's disease and a therapeutic drug thereof, belonging to the technical field of medical science and solving the problem that the Raynaud's disease is easy to recur when being treated by using western medicines. By virtue of analysis, the symptoms of the Raynaud's disease appear on the skin surface but the pathogenesis is caused by the internal factors of a human body; the Raynaud's disease belongs to excess of yin due to yang insufficiency, qi asthenia as well as qi stagnation and blood stasis; and the Raynaud's disease is treated by adopting a traditional Chinese medicine combination with the effects of nourishing yin and strengthening yang, nourishing qi and blood as well as promoting blood circulation to remove meridian obstruction. The therapeutic drug is prepared from the following ingredients in parts by weight: 15 parts of safflower, 15 parts of forsythia, 15 parts of isatis leaf, 15 parts of felwort, 15 parts of honeysuckle, 15 parts of radix rehmanniae, 10 parts of seaweed, 10 parts of kelp, 15 parts of achyranthes root, 15 parts of dangshen, 10 parts of leech, 10 parts of fiveleaf akebia, 10 parts of peach kernel and 7 parts of licorice. The therapeutic effect is obvious and stable.
Description
Technical field
The present invention relates to Raynaud disease and medicine thereof, particularly with the medicine of traditional Chinese medical herbal treatment, belong to medicine technology field.
Background technology
Raynaud disease (English: Raynauddisease) also claims Reynolds syndrome, is the acra arteriolospasm disease being nervus vasculairs dysfunction and causing.Be its Clinical symptoms with Raynaud's phenomenons such as paroxysmal extremity distal symmetrical skin whitening, cyanosis, flushing.This disease is more common in women, and man, female's disease rates are about 1: 10.Age of onset is many between 20 ~ 30 years old, absolutely less more than 40 years old.Great majority see cold area.Send out cold season well.Raynaud disease is vascular function disease, most typical Symptoms be both hands both feet when meeting cold or excited after there is pale, cyanosis, flushing episode process, recover normal after warming gradually.Mostly be women's morbidity.Their early stage both hands Symptoms is obvious, and the course of disease can involve biped for a long time Symptoms.Have the women of this Symptoms, generally will check immune system, show as Raynaud's phenomenon at first because of what have a disease of immune system, disease of immune system comprises systemic lupus erythematosus vasculitis or rheumatic vasculitis etc.In this way simple Raynaud's phenomenon or Raynaud's syndrome treatment and more after all better, if delay treatment can not recover normal.As delay treatment, final development final result is similar to three phases of thromboangiitis obliterans, there will be ulcer that finger (toe) holds, necrosis.The main clinical manifestation of Raynaud disease is when cold stimulation or psychentonia, and typical Raynaud phenomenon appears in finger skin, i.e. pale, cyanosis, flushing, normal intermittent color of the leather change.When finger presents pale and cyanosis, finger tips can with numbness, twinge, send out cool and insensitive.
After taking warming measure. hand color of the leather just becomes flushing color, and Pi Wenchang rises, and now can have slight to burn sample distending pain.Then color of the leather is normal, and above-mentioned symptom disappears thereupon.At the initial stage of morbidity, have obvious seasonality, namely outbreak cold season is frequent and the arteriospasm persistent period is longer, and the number of times minimizing shown effect in warm season, the arteriospasm persistent period is shorter, or seldom shows effect.The state of an illness comparatively severe one is more responsive to cold, therefore in the winter time can not in outdoor activity and work.
Raynaud disease complication: it is cold that Raynaud disease can make thin vessels close, result causes digit ischemic downright bad.Severe patient can occur referring to that (toe) end refers to that abdomen flattens, gangrene, phalangette can downright bad because of ischemia, absorbed, dissolved, occurring shortening or section finger phenomenon.The patient that some are had a low resistance, digit ischemic and ulcer occurs likely cause the disease such as osteomyelitis, septicemia, this is also the most serious complication of primary disease, correctly and in time applies the generation that anti-infectives contributes to preventing these complication.
The Raynaud disease cause of disease is still not exclusively clear and definite at present.Cold stimulation, emotion hormone or psychentonia are main motivating factors.Other inducements are as infection, fatigue etc.Because state of an illness menstrual phase of being everlasting increases the weight of, alleviate in trimester of pregnancy, therefore, someone thinks that this disease may be relevant with gonad function.
The treatment of Raynaud disease: Drug therapy has (1) calcium ion antagonist, nifedipine, diltiazem; (2) reserpine; (3) α receptor antagonist, prazosin etc., western medicine is obviously effective, but is easy to recurrence.Operative treatment: can sympathectomy be considered to medicine nonresponder, but curative effect needs to be observed further.
Summary of the invention
chinese medicine fundamentally can analyze the cause of disease, thus suits the remedy to the case, to reach the object for the treatment of both the principal and secondary aspects of a disease.Analyze Raynaud disease with Chinese medicine, the symptom of Raynaud disease is at skin surface, but the cause of disease is at inside of human body, belongs toexcess of YIN due to YANG-insufficiency, healthy energy are failed, qi depression to blood stasis, and treatment should with YIN nourishing and YANG strengthening, invigorating qi and benefiting blood, and the Chinese medicine composition of promoting blood circulation to remove obstruction in the collateral is taken as treating scheme.
Raynaud disease and medicine thereof taked technical scheme of dealing with problems combines by each Chinese medicine quality part ratio below: 15 parts, Flos Carthami, Fructus Forsythiae 15 parts, Folium Isatidis 15 parts, Radix Gentianae 15 parts, Flos Lonicerae 15 parts, 15 parts, the Radix Rehmanniae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 10 parts, Radix Achyranthis Bidentatae 15 parts, Radix Codonopsis 15 parts, Hirudo 10 parts, Caulis Akebiae 10 parts, 10 parts, Semen Persicae, 7 parts, Radix Glycyrrhizae.
Property of medicine effect of each Chinese medicine in lower surface analysis Raynaud disease and medicine thereof.Chinese medicine safflower effect: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving, control amenorrhea ， mass in the abdomen, disease that postpartum lochia can't go, blood stasis are had a pain, carbuncle, injury from falling down.Fructus Forsythiae effect: heat clearing away, removing toxic substances, eliminating stagnation, detumescence, controls warm, erysipelas, macule, carbuncle and ulcer toxic swelling, scrofula, urine stranguria with urinary obstruction.Folium Isatidis effect: heat clearing away, removing toxic substances, removing heat from blood, hemostasis, controls epidemic febrile disease intenseness of heat excessive thirst, influenza, acute infectious hepatitis, bacillary dysentery, acute gastroenteritis, acute pneumonia, erysipelas, spits blood, epistaxis, jaundice, dysentery, sore throat, aphtha, swollen ulcer drug.The function of Radix Gentianae is: heat clearing and damp drying, eliminating pathogen in the liver gallbladder excess-fire, for jaundice due to damp-heat, leukorrhagia, eczema scrotum, and the puckery pain of pyretic stranguria oliguria with reddish urine; Liver flaming-up of gallbladder-fire causes conjunctival congestion and swelling pain, and deaf ear is swollen, costalgia; Acute infantile convulsion, the diseases such as high fever tic.One of conventional rare Chinese medicine of Flos Lonicerae system, has the effects such as heat-clearing and toxic substances removing, dredge the meridian passage, broad-spectrum antiseptic and antiviral, all contains Flos Lonicerae, have " Chinese medicine antibiotic " laudatory title in the flu of more than 70%, antiinflammatory Chinese patent medicine.Radix Rehmanniae clearing away heat and cooling blood, promote the production of body fluid and invigorate blood circulation, stop blooding.Sargassum energy Tumor suppression, has effect of health care, enhancing immunity, anticancer, antitumor, anticoagulation, thrombosis of losing weight, prevent.Thallus Laminariae (Thallus Eckloniae): hard masses softening and resolving, expectorant, diuretic, for goiter, scrofula, painful and swollen testis, phlegm retention edema.Radix Achyranthis Bidentatae effect: eliminating blood stasis and inducing menstruation, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards, for amenorrhea, dysmenorrhea, soreness of waist and knee joint.Radix Codonopsis is put down, and sweet in the mouth, micro-acid, return spleen, lung meridian, invigorating the spleen and replenishing QI, and spleen invigorating lung benefiting can strengthen the immunity of people; For deficiency of the spleen and lung, cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency is coughed, and interior-heat is quenched one's thirst.Hirudo effect: removing blood stasis, removing blood stasis, stimulates the menstrual flow, and control blood-retention ， mass in the abdomen, gather, women's amenorrhea, blood stasis becomes consumptive disease, injury from falling down, and order is pain also, nebula.Caulis Akebiae pathogenic fire purging row water, promoting blood circulation, controls hot urination, stranguria with turbid discharge, edema, irritable feverish sensation in the chest, sore throat pharyngalgia, inflexible pain all over, women's amenorrhea, galactostasis.Semen Persicae can improve hemodynamic situation, promotes bile secretion, has inhibitory action, and have fiber facilitation, be beneficial to defecation to external thrombus, can promote primipara's uterine contraction and hemorrhage have analgesia, antiinflammatory, antibacterial, anti-allergic effects.Radix Glycyrrhizae is relieving cough and expelling phlegm medicine, and effect is rather extensive, in Chinese medicine decoction and Chinese patent medicine compatibility, and effect of its QI invigorating strengthening the spleen conventional and middle emergency, coordinating the actions of various ingredients in a prescription.
Raynaud disease and the medicine beneficial effect of the invention thereof are: Raynaud disease and medicine thereof are by analyzing Raynaud disease with tcm theory
symptom at skin surface, but the cause of disease is at inside of human body, belongs toexcess of YIN due to YANG-insufficiency, healthy energy are failed, qi depression to blood stasis, and with YIN nourishing and YANG strengthening, invigorating qi and benefiting blood, the Chinese medicine composition of promoting blood circulation to remove obstruction in the collateral takes the scheme for the treatment of, and curative effect is obvious, treating both the principal and secondary aspects of a disease, solves the problem that external Western medicine repeats to show effect.
Detailed description of the invention
Raynaud disease and medicine thereof combine by each Chinese medicine quality part ratio below: 15 parts, Flos Carthami, Fructus Forsythiae 15 parts, Folium Isatidis 15 parts, Radix Gentianae 15 parts, Flos Lonicerae 15 parts, 15 parts, the Radix Rehmanniae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 10 parts, Radix Achyranthis Bidentatae 15 parts, Radix Codonopsis 15 parts, Hirudo 10 parts, Caulis Akebiae 10 parts, 10 parts, Semen Persicae, 7 parts, Radix Glycyrrhizae.By said medicine usage ratio, being suitable for a dosage dose that a Raynaud disease patient takes is combine by each Chinese medicine quality below: 15 grams, Flos Carthami, Fructus Forsythiae 15 grams, Folium Isatidis 15 grams, Radix Gentianae 15 grams, Flos Lonicerae 15 grams, 15 grams, the Radix Rehmanniae, Sargassum 10 grams, Thallus Laminariae (Thallus Eckloniae) 10 grams, Radix Achyranthis Bidentatae 15 grams, Radix Codonopsis 15 grams, Hirudo 10 grams, Caulis Akebiae 10 grams, 10 grams, Semen Persicae, 7 grams, Radix Glycyrrhizae.Using method: decoct soup and take medicinal liquid orally, day takes dose, serve on and is almost recovered in a week.
Claims (1)
1. Raynaud disease and medicine thereof, is characterized in that combining by each Chinese medicine quality part ratio below: 15 parts, Flos Carthami, Fructus Forsythiae 15 parts, Folium Isatidis 15 parts, Radix Gentianae 15 parts, Flos Lonicerae 15 parts, 15 parts, the Radix Rehmanniae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 10 parts, Radix Achyranthis Bidentatae 15 parts, Radix Codonopsis 15 parts, Hirudo 10 parts, Caulis Akebiae 10 parts, 10 parts, Semen Persicae, 7 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510644592.5A CN105194068A (en) | 2015-10-09 | 2015-10-09 | Raynaud's disease and therapeutic drug thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510644592.5A CN105194068A (en) | 2015-10-09 | 2015-10-09 | Raynaud's disease and therapeutic drug thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105194068A true CN105194068A (en) | 2015-12-30 |
Family
ID=54942253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510644592.5A Pending CN105194068A (en) | 2015-10-09 | 2015-10-09 | Raynaud's disease and therapeutic drug thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105194068A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727079A (en) * | 2016-04-19 | 2016-07-06 | 劳炳凤 | Treatment drug for skin ulcers |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1277846A (en) * | 2000-02-13 | 2000-12-27 | 任国祥 | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons |
| CN104043087A (en) * | 2014-06-25 | 2014-09-17 | 梁黎明 | Traditional Chinese medicine composition for treating Raynaud syndrome |
| CN104383510A (en) * | 2014-12-05 | 2015-03-04 | 毛华养 | Traditional Chinese medicine mixture for treating Raynaud's disease |
-
2015
- 2015-10-09 CN CN201510644592.5A patent/CN105194068A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1277846A (en) * | 2000-02-13 | 2000-12-27 | 任国祥 | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons |
| CN104043087A (en) * | 2014-06-25 | 2014-09-17 | 梁黎明 | Traditional Chinese medicine composition for treating Raynaud syndrome |
| CN104383510A (en) * | 2014-12-05 | 2015-03-04 | 毛华养 | Traditional Chinese medicine mixture for treating Raynaud's disease |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727079A (en) * | 2016-04-19 | 2016-07-06 | 劳炳凤 | Treatment drug for skin ulcers |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104367911A (en) | Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
| CN104623561A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN103861074A (en) | Traditional Chinese medicinal composition for treating menopausal arthritis | |
| CN103536858A (en) | Medicine for treating rheumatoid arthritis | |
| CN104435694A (en) | External traditional Chinese medicine medicated wine for treating rheumatism | |
| CN104258289A (en) | Traditional Chinese medicine for treating enteritis | |
| CN105535371A (en) | Traditional Chinese medicine for treating gonarthromeningitis | |
| CN102861296B (en) | Pill inducing diuresis and reducing edema for treating gonarthromeningitis | |
| CN103977362A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands and early-stage breast cancer | |
| CN103599486B (en) | A kind of Chinese medicine composition of orally taken for curing rheumatoid arthritis | |
| CN104548054A (en) | Traditional Chinese medicine composition for treating gynecological diseases and preparation methods of traditional Chinese medicine composition | |
| CN104825561A (en) | Traditional Chinese medicine for treating arthritis | |
| CN105194068A (en) | Raynaud's disease and therapeutic drug thereof | |
| CN104383479A (en) | Traditional Chinese medicine foot bath composition for treating varicosity and preparation method of traditional Chinese medicine foot bath composition | |
| CN104383384A (en) | Traditional Chinese medicine washing liquid for treating tinea of feet and hands | |
| CN104107393A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN104147512A (en) | Traditional Chinese medicine composition for treating wet and cold type sciatica | |
| CN104352667A (en) | Medicine for treating nonspecific vaginitis and preparation method | |
| CN104398927A (en) | Traditional Chinese medicinal preparation for treating gonarthromeningitis | |
| CN103933299A (en) | Chinese herbal preparation for treating rheumatic arthritis | |
| CN104491800A (en) | Traditional Chinese medicine composition for treating chronic colitis | |
| CN103948763A (en) | Traditional Chinese medicinal composition for treating hepatosis | |
| CN103845583B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis | |
| CN104547232A (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN102000268B (en) | Chinese medicinal oral preparation for treating rheumatism and rheumatoid diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151230 |